We’ll give you Roger’s top picks right now (but we won’t share his price target unless you attend the seminar):
XLV - Roger believes government spending will only increase in the health sector in 2022.
XLY - Woah, woah, woah… Roger is urging traders not to go buying this one… Here’s why you should avoid it
CROX - This is one of Rogers best picks this past year, and he doesn’t think it’s slowing down… Want the price target for this mid cap stock? Watch the webinar!
Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.
The profits and performance shown are not typical, we make no future earnings claims, and you may lose money.
Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.
Post a Comment
0Comments